Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
120,138,422
-
Total 13F shares
-
33,776,828
-
Share change
-
+1,093,678
-
Total reported value
-
$1,021,408,758
-
Price per share
-
$30.24
-
Number of holders
-
55
-
Value change
-
+$33,104,690
-
Number of buys
-
32
-
Number of sells
-
14
Institutional Holders of Arcutis Biotherapeutics, Inc. - Common Stock (ARQT) as of Q2 2020
As of 30 Jun 2020 Arcutis Biotherapeutics, Inc. - Common Stock (ARQT) had 55 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 33,776,828 shares of stock of the company.
Largest 10 holders included FRAZIER MANAGEMENT LLC, FMR LLC, ORBIMED ADVISORS LLC, Bain Capital Life Sciences Investors, LLC, BlackRock Inc., Vivo Capital, LLC, RA CAPITAL MANAGEMENT, L.P., PRICE T ROWE ASSOCIATES INC /MD/, Omega Fund Management, LLC, and WELLS FARGO & COMPANY/MN.
This table shows 55 institutional shareholders of the security as of 30 Jun 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.